Hiroaki Hashizume

1.2k total citations
15 papers, 307 citations indexed

About

Hiroaki Hashizume is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Hiroaki Hashizume has authored 15 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Surgery and 6 papers in Hepatology. Recurrent topics in Hiroaki Hashizume's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (3 papers) and Hepatitis C virus research (3 papers). Hiroaki Hashizume is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (3 papers) and Hepatitis C virus research (3 papers). Hiroaki Hashizume collaborates with scholars based in Japan, United States and Germany. Hiroaki Hashizume's co-authors include Ken Sato, Satoru Kakizaki, Norio Horiguchi, Yuichi Yamazaki, Masatomo Mori, Motoyasu Kusano, Masanobu Yamada, Hitoshi Takagi, Naondo Sohara and Susumu Ohwada and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Hiroaki Hashizume

13 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroaki Hashizume Japan	9	202	147	117	67	59	15	307
Tokiko Ishida Japan	5	158 0.8×	115 0.8×	59 0.5×	30 0.4×	68 1.2×	6	307
Ryan S. Huss United States	9	368 1.8×	160 1.1×	85 0.7×	156 2.3×	126 2.1×	16	523
Shinji Iwane Japan	11	241 1.2×	237 1.6×	76 0.6×	33 0.5×	65 1.1×	34	425
Liangwen Wang China	5	199 1.0×	112 0.8×	50 0.4×	95 1.4×	153 2.6×	8	373
Varun Takyar United States	10	316 1.6×	236 1.6×	50 0.4×	67 1.0×	49 0.8×	21	412
Courtney B. Sherman United States	5	142 0.7×	142 1.0×	94 0.8×	30 0.4×	52 0.9×	14	318
Amelia Sybenga United States	10	105 0.5×	82 0.6×	89 0.8×	23 0.3×	47 0.8×	16	259
Michele Zuckermann Italy	7	133 0.7×	136 0.9×	123 1.1×	35 0.5×	73 1.2×	13	342
Lee C. Claridge United Kingdom	5	166 0.8×	99 0.7×	39 0.3×	68 1.0×	81 1.4×	8	279
Dhananjay Kumar India	10	131 0.6×	115 0.8×	62 0.5×	18 0.3×	64 1.1×	22	291

Countries citing papers authored by Hiroaki Hashizume

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Hashizume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Hashizume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Hashizume more than expected).

Fields of papers citing papers by Hiroaki Hashizume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Hashizume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Hashizume. The network helps show where Hiroaki Hashizume may publish in the future.

Co-authorship network of co-authors of Hiroaki Hashizume

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Hashizume. A scholar is included among the top collaborators of Hiroaki Hashizume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Hashizume. Hiroaki Hashizume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mori, Naoko, Shunji Mugikura, Atsushi Hozawa, et al.. (2025). Language Registration-Based Scoring System for Handwritten Logical Memory of Wechsler Memory Scale-Revised: Developed and Validated in the Tohoku Medical Megabank Project. The Tohoku Journal of Experimental Medicine. 267(1). 59–69.

Yamazaki, Yuichi, Hiroaki Hashizume, Takeshi Kobayashi, et al.. (2016). Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation. Clinical Journal of Gastroenterology. 9(1). 27–31. 2 indexed citations

Sato, Ken, Atsushi Naganuma, Takashi Hoshino, et al.. (2016). Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin. Gastroenterology. 150(4). S1107–S1107.

Yamazaki, Yuichi, Ken Sato, Satoru Kakizaki, et al.. (2015). The relationship between renin angiotensin system inhibitor and serum potassium increase during combination therapy with Daclatasvir and Asnaplevir for chronic hepatitis C. Kanzo. 56(7). 324–331. 2 indexed citations

Seki, Yosuke, Satoru Kakizaki, Norio Horiguchi, et al.. (2015). Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. Journal of Gastroenterology. 51(3). 281–289. 34 indexed citations

Sato, Ken, Yuichi Yamazaki, Hiroaki Hashizume, et al.. (2015). A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia. The American Journal of Gastroenterology. 110(3). 423–431. 78 indexed citations

Ohyama, Tatsuya, Ken Sato, Yuichi Yamazaki, et al.. (2014). MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis inob/obmice. World Journal of Gastroenterology. 20(43). 16227–16227. 26 indexed citations

Motegi, Sei‐ichiro, Yoko Yokoyama, Akihiko Uchiyama, et al.. (2014). First Japanese case of atypical progeroid syndrome/atypical Werner syndrome with heterozygous LMNA mutation. The Journal of Dermatology. 41(12). 1047–1052. 22 indexed citations

Sato, Ken, Yuichi Yamazaki, Tatsuya Ohyama, et al.. (2013). Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation. Laboratory Investigation. 93(6). 720–732. 26 indexed citations

10.

Hashizume, Hiroaki, Ken Sato, Yuichi Yamazaki, et al.. (2013). A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts.. PubMed. 67(1). 45–53. 15 indexed citations

11.

Sato, Ken, Hiroaki Hashizume, Yuichi Yamazaki, et al.. (2012). Response‐guided peginterferon‐alpha‐2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads. Hepatology Research. 42(9). 854–863. 9 indexed citations

12.

Hashizume, Hiroaki, Ken Sato, Norio Horiguchi, et al.. (2012). A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk factors: successful treatment with argon plasma coagulation. Clinical Journal of Gastroenterology. 5(5). 336–340. 1 indexed citations

13.

Kakizaki, Satoru, Yuichi Yamazaki, Hiroaki Hashizume, et al.. (2011). The status and problems in subsidizing interferon treatment in Gunma prefecture. Kanzo. 52(5). 287–294. 1 indexed citations

14.

Hashizume, Hiroaki, Ken Sato, Hitoshi Takagi, et al.. (2007). Primary liver cancers with nonalcoholic steatohepatitis. European Journal of Gastroenterology & Hepatology. 19(10). 827–834. 63 indexed citations

15.

Takagi, Hitoshi, Satoshi Hagiwara, Hiroaki Hashizume, et al.. (2005). Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis. Journal of Hepatology. 44(1). 236–239. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact